Skip to main content

Table 4 Multivariate analysis for recurrence-free survival (RFS) and overall survival (OS)

From: Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer

  RFS OS
  HR Conf. int. p-value HR Conf. int. p-value
Normal ECOG 0.5212 0.28515
0.9526
0.521 0.4027 0.2384
0.6804
< 0.001
No smoking history 0.4191 0.09899
1.7739
0.237 0.4887 0.1733
1.3786
0.176
Chemotherapy
(full dose)
0.9337 0.50318
1.7328
0.828 0.8130 0.4757
1.3892
0.449
Tumor volume 1.0111 1.00454
1.0177
0.036 1.0077 1.0016
1.0138
0.013
NLR 3.0218 1.67305
5.4579
< 0.001 1.7333 1.0462
2.8718
0.033
\